Skip to main content
Erschienen in:

10.12.2019 | Special Edition

The diagnosis and treatment of lung cancer presented as ground-glass nodule

verfasst von: Ke-Neng Chen

Erschienen in: General Thoracic and Cardiovascular Surgery | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Pulmonary nodules that manifest as ground-glass opacity are particularly challenging on account of their malignant potential and heterogeneous characteristics. The “ground-glass nodule-like” lung cancer is different from the conventional lung cancer. This review focuses on the radiologic and pathologic classifications of ground-glass nodules, along with the staging and clinical management of these lesions. In addition, we discuss the lung cancer high-risk population shift and follow-up of ground-glass nodules in the light of experience from screening trials. The standard of care surgical treatment of early lung cancer is still lobectomy with systematic lymph node dissection. However, a recent research has shown that some ground-glass nodules may be treated with sublobar resections or non-surgical treatment; these findings may expand the treatment options available in the future.
Literatur
1.
Zurück zum Zitat Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.PubMed Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.PubMed
2.
Zurück zum Zitat National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409.CrossRef National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409.CrossRef
3.
Zurück zum Zitat Todo G, Ito H, Nakano Y, Dodo Y, Maeda H, Murata K, et al. High resolution CT (HR-CT) for the evaluation of pulmonary peripheral disorders. Rinsho Hoshasen. 1982;27(12):1319–26.PubMed Todo G, Ito H, Nakano Y, Dodo Y, Maeda H, Murata K, et al. High resolution CT (HR-CT) for the evaluation of pulmonary peripheral disorders. Rinsho Hoshasen. 1982;27(12):1319–26.PubMed
4.
Zurück zum Zitat Naidich DP, McCauley DI, Siegelman SS. Computed tomography of bronchial adenomas. J Comput Assist Tomogr. 1982;6(4):725–32.PubMedCrossRef Naidich DP, McCauley DI, Siegelman SS. Computed tomography of bronchial adenomas. J Comput Assist Tomogr. 1982;6(4):725–32.PubMedCrossRef
5.
Zurück zum Zitat Nakata H, Ishimaru H, Nakayama C, Yoshimatsu H. Computed tomography for preoperative evaluations of lung cancer. J Comput Tomogr. 1986;10(2):147–51.PubMedCrossRef Nakata H, Ishimaru H, Nakayama C, Yoshimatsu H. Computed tomography for preoperative evaluations of lung cancer. J Comput Tomogr. 1986;10(2):147–51.PubMedCrossRef
6.
Zurück zum Zitat Zerhouni EA, Stitik FP, Siegelman SS, Naidich DP, Sagel SS, Proto AV, et al. CT of the pulmonary nodule: a cooperative study. Radiology. 1986;160(2):319–27.PubMedCrossRef Zerhouni EA, Stitik FP, Siegelman SS, Naidich DP, Sagel SS, Proto AV, et al. CT of the pulmonary nodule: a cooperative study. Radiology. 1986;160(2):319–27.PubMedCrossRef
7.
Zurück zum Zitat Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008;246(3):697–722.PubMedCrossRef Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008;246(3):697–722.PubMedCrossRef
8.
Zurück zum Zitat Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer. 1995;75(12):2844–52.PubMedCrossRef Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer. 1995;75(12):2844–52.PubMedCrossRef
9.
Zurück zum Zitat Suzuki K, Kusumoto M, Watanabe S, Tsuchiya R, Asamura H. Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact. Ann Thorac Surg. 2006;81(2):413–9.PubMedCrossRef Suzuki K, Kusumoto M, Watanabe S, Tsuchiya R, Asamura H. Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact. Ann Thorac Surg. 2006;81(2):413–9.PubMedCrossRef
10.
Zurück zum Zitat Kakinuma R, Noguchi M, Ashizawa K, Kuriyama K, Maeshima AM, Koizumi N, et al. Natural history of pulmonary subsolid nodules: a prospective multicenter study. J Thorac Oncol. 2016;11(7):1012–28.PubMedCrossRef Kakinuma R, Noguchi M, Ashizawa K, Kuriyama K, Maeshima AM, Koizumi N, et al. Natural history of pulmonary subsolid nodules: a prospective multicenter study. J Thorac Oncol. 2016;11(7):1012–28.PubMedCrossRef
11.
Zurück zum Zitat Travis WD, Asamura H, Bankier AA, Beasley MB, Detterbeck F, Flieder DB, et al. The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol. 2016;11(8):1204–23.PubMedCrossRef Travis WD, Asamura H, Bankier AA, Beasley MB, Detterbeck F, Flieder DB, et al. The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol. 2016;11(8):1204–23.PubMedCrossRef
12.
Zurück zum Zitat Suzuki S, Sakurai H, Yotsukura M, Masai K, Asakura K, Nakagawa K, et al. Clinical features of ground glass opacity-dominant lung cancer exceeding 3.0 cm in the whole tumor size. Ann Thorac Surg. 2018;105(5):1499–506.PubMedCrossRef Suzuki S, Sakurai H, Yotsukura M, Masai K, Asakura K, Nakagawa K, et al. Clinical features of ground glass opacity-dominant lung cancer exceeding 3.0 cm in the whole tumor size. Ann Thorac Surg. 2018;105(5):1499–506.PubMedCrossRef
13.
Zurück zum Zitat Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6(2):244–85.PubMedPubMedCentralCrossRef Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6(2):244–85.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10(9):1243–60.PubMedCrossRef Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10(9):1243–60.PubMedCrossRef
15.
Zurück zum Zitat Sawada S, Yamashita N, Sugimoto R, Ueno T, Yamashita M. Long-term outcomes of patients with ground-glass opacities detected using CT scanning. Chest. 2017;151(2):308–15.PubMedCrossRef Sawada S, Yamashita N, Sugimoto R, Ueno T, Yamashita M. Long-term outcomes of patients with ground-glass opacities detected using CT scanning. Chest. 2017;151(2):308–15.PubMedCrossRef
16.
Zurück zum Zitat Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, et al. Cancer screening in the United States, 2019: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2019;69(3):184–210.PubMedCrossRef Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, et al. Cancer screening in the United States, 2019: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2019;69(3):184–210.PubMedCrossRef
18.
Zurück zum Zitat Rampinelli C, De Marco P, Origgi D, Maisonneuve P, Casiraghi M, Veronesi G, et al. Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis. BMJ. 2017;356:j347.PubMedPubMedCentralCrossRef Rampinelli C, De Marco P, Origgi D, Maisonneuve P, Casiraghi M, Veronesi G, et al. Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis. BMJ. 2017;356:j347.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Mazzone PJ, Silvestri GA, Patel S, Kanne JP, Kinsinger LS, Wiener RS, et al. Screening for lung cancer: CHEST guideline and expert panel report. Chest. 2018;153(4):954–85.PubMedCrossRef Mazzone PJ, Silvestri GA, Patel S, Kanne JP, Kinsinger LS, Wiener RS, et al. Screening for lung cancer: CHEST guideline and expert panel report. Chest. 2018;153(4):954–85.PubMedCrossRef
20.
Zurück zum Zitat Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60(3):615–22 (discussion 622–623).PubMedCrossRef Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60(3):615–22 (discussion 622–623).PubMedCrossRef
21.
Zurück zum Zitat Sesti J, Donington JS. Sublobar resection: ongoing controversy for treatment for stage I non-small cell lung cancer. Thorac Surg Clin. 2016;26(3):251–9.PubMedCrossRef Sesti J, Donington JS. Sublobar resection: ongoing controversy for treatment for stage I non-small cell lung cancer. Thorac Surg Clin. 2016;26(3):251–9.PubMedCrossRef
22.
Zurück zum Zitat Altorki NK, Wang X, Wigle D, Gu L, Darling G, Ashrafi AS, et al. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Lancet Respir Med. 2018;6(12):915–24.PubMedPubMedCentralCrossRef Altorki NK, Wang X, Wigle D, Gu L, Darling G, Ashrafi AS, et al. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Lancet Respir Med. 2018;6(12):915–24.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Schneider BJ, Daly ME, Kennedy EB, Antonoff MB, Broderick S, Feldman J, et al. Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: American Society of Clinical Oncology endorsement of the American Society for Radiation Oncology evidence-based guideline. J Clin Oncol. 2018;36(7):710–9.PubMedCrossRef Schneider BJ, Daly ME, Kennedy EB, Antonoff MB, Broderick S, Feldman J, et al. Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: American Society of Clinical Oncology endorsement of the American Society for Radiation Oncology evidence-based guideline. J Clin Oncol. 2018;36(7):710–9.PubMedCrossRef
24.
Zurück zum Zitat Detterbeck FC. Achieving clarity about lung cancer and opacities. Chest. 2017;151(2):252–4.PubMedCrossRef Detterbeck FC. Achieving clarity about lung cancer and opacities. Chest. 2017;151(2):252–4.PubMedCrossRef
Metadaten
Titel
The diagnosis and treatment of lung cancer presented as ground-glass nodule
verfasst von
Ke-Neng Chen
Publikationsdatum
10.12.2019
Verlag
Springer Singapore
Erschienen in
General Thoracic and Cardiovascular Surgery / Ausgabe 7/2020
Print ISSN: 1863-6705
Elektronische ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-019-01267-4

Neu im Fachgebiet Chirurgie

Ab sofort gelten die neuen Verordnungsausnahmen für Lipidsenker

Freie Fahrt für Lipidsenker? Das nicht, doch mit niedrigerem Schwellenwert fürs Infarktrisiko und neuen Indikationen hat der G-BA die Verordnungs-Handbremse ein gutes Stück weit gelockert.

Appendizitis und Darminfarkt durch Blinddarm-Lipom

Eigentlich sind Lipome recht harmlos. Im Zäkum können sie jedoch erhebliche Komplikationen mit Darminfarkt und Appendizitis verursachen.

Gluteuslappen nach Rektumkarzinom-Op. schützt vor Abszessen

Die Wunddeckung mit einem autologen Rotationslappen nach Entfernung eines Rektumkarzinoms konnte in einer randomisierten Studie gegenüber dem primären Wundverschluss vor allem in einer Hinsicht punkten: Sie führte deutlich seltener zu präsakralen Abszessen.

Webinar

MedTalk Leitlinie KOMPAKT: S3-Leitline zu peripheren Nervenverletzungen

  • Webinar | 10.02.2025 | 13:00

Über den Weg zur finalen Fassung der S3-Leitlinie "Versorgung peripherer Nervenverletzungen" spricht Prof. Dr. Leila Harhaus-Wähner im MedTalk Leitlinie KOMPAKT. In dem kurzen Video geht es darum, was sich im Vergleich zur vorigen Fassung der Leitlinie geändert hat, welche Aspekte für die tägliche Praxis besonders wichtig sind und was jeder gemäß Leitlinie nun anders oder besser machen sollte.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.